DE3100156A1 - Material zur bestimmung der haemoglobinkonzentration - Google Patents
Material zur bestimmung der haemoglobinkonzentrationInfo
- Publication number
- DE3100156A1 DE3100156A1 DE19813100156 DE3100156A DE3100156A1 DE 3100156 A1 DE3100156 A1 DE 3100156A1 DE 19813100156 DE19813100156 DE 19813100156 DE 3100156 A DE3100156 A DE 3100156A DE 3100156 A1 DE3100156 A1 DE 3100156A1
- Authority
- DE
- Germany
- Prior art keywords
- hydrophilic
- concentration
- blood
- spreading layer
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010054147 Hemoglobins Proteins 0.000 title claims description 27
- 102000001554 Hemoglobins Human genes 0.000 title claims description 27
- 239000000463 material Substances 0.000 title claims description 20
- 238000003892 spreading Methods 0.000 claims description 52
- 230000007480 spreading Effects 0.000 claims description 52
- 239000011230 binding agent Substances 0.000 claims description 21
- 230000005660 hydrophilic surface Effects 0.000 claims description 3
- 241000276498 Pollachius virens Species 0.000 claims 1
- 210000004369 blood Anatomy 0.000 description 43
- 239000008280 blood Substances 0.000 description 43
- 239000000523 sample Substances 0.000 description 42
- 230000003287 optical effect Effects 0.000 description 25
- 238000000034 method Methods 0.000 description 20
- 239000007864 aqueous solution Substances 0.000 description 16
- 239000011148 porous material Substances 0.000 description 13
- 239000012528 membrane Substances 0.000 description 10
- 108010010803 Gelatin Proteins 0.000 description 9
- 229920000159 gelatin Polymers 0.000 description 9
- 239000008273 gelatin Substances 0.000 description 9
- 235000019322 gelatine Nutrition 0.000 description 9
- 235000011852 gelatine desserts Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000005259 measurement Methods 0.000 description 8
- 239000004753 textile Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 210000003743 erythrocyte Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920002799 BoPET Polymers 0.000 description 5
- 230000002949 hemolytic effect Effects 0.000 description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- -1 organic acid salts Chemical class 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 229920002284 Cellulose triacetate Polymers 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 238000000149 argon plasma sintering Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 239000006174 pH buffer Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- FRPHFZCDPYBUAU-UHFFFAOYSA-N Bromocresolgreen Chemical compound CC1=C(Br)C(O)=C(Br)C=C1C1(C=2C(=C(Br)C(O)=C(Br)C=2)C)C2=CC=CC=C2S(=O)(=O)O1 FRPHFZCDPYBUAU-UHFFFAOYSA-N 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920004896 Triton X-405 Polymers 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000002587 anti-hemolytic effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229920000402 bisphenol A polycarbonate polymer Polymers 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000011152 fibreglass Substances 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 108010036302 hemoglobin AS Proteins 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002433 hydrophilic molecules Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000007793 ph indicator Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/525—Multi-layer analytical elements
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP43580A JPS5697872A (en) | 1980-01-07 | 1980-01-07 | Measuring material for concentration of hemoglobin in blood |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3100156A1 true DE3100156A1 (de) | 1982-02-11 |
| DE3100156C2 DE3100156C2 (US06515009-20030204-C00004.png) | 1988-11-10 |
Family
ID=11473726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19813100156 Granted DE3100156A1 (de) | 1980-01-07 | 1981-01-07 | Material zur bestimmung der haemoglobinkonzentration |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4337222A (US06515009-20030204-C00004.png) |
| JP (1) | JPS5697872A (US06515009-20030204-C00004.png) |
| DE (1) | DE3100156A1 (US06515009-20030204-C00004.png) |
| GB (1) | GB2069132B (US06515009-20030204-C00004.png) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58139067A (ja) * | 1982-02-12 | 1983-08-18 | Fuji Photo Film Co Ltd | 液体試料の測定法 |
| US4491012A (en) * | 1982-10-04 | 1985-01-01 | Nuclepore Corp. | Method for measuring erythrocyte deformability |
| US4478944A (en) * | 1982-11-24 | 1984-10-23 | Eastman Kodak Company | Analytical element containing a barrier zone and process employing same |
| JPS59108942A (ja) * | 1982-12-14 | 1984-06-23 | Fuji Photo Film Co Ltd | シ−ト状分析要素を用いる定量方法 |
| JPS60222769A (ja) * | 1984-04-19 | 1985-11-07 | Fuji Photo Film Co Ltd | 一体型多層分析要素 |
| US4880749A (en) * | 1984-06-05 | 1989-11-14 | Eastman Kodak Company | Analytical element and its use in a whole blood hemoglobin assay |
| JPS614959A (ja) * | 1984-06-19 | 1986-01-10 | Fuji Photo Film Co Ltd | 一体型多層分析要素 |
| US4790979A (en) * | 1986-08-29 | 1988-12-13 | Technimed Corporation | Test strip and fixture |
| US4810470A (en) * | 1987-06-19 | 1989-03-07 | Miles Inc. | Volume independent diagnostic device |
| JPH0677010B2 (ja) * | 1987-12-28 | 1994-09-28 | 富士写真フイルム株式会社 | 一体型多層分析要素 |
| US5215716A (en) * | 1987-12-28 | 1993-06-01 | Fuji Photo Film Co., Ltd. | Integral multilayer analytical element |
| JP2654682B2 (ja) * | 1989-02-17 | 1997-09-17 | 富士写真フイルム株式会社 | 生化学分析装置、生化学分析補正方法及び補正値記録体 |
| DE19523049A1 (de) * | 1995-06-24 | 1997-01-02 | Boehringer Mannheim Gmbh | Mehrschichtiges Analysenelement zur Bestimmung eines Analyten in einer Flüssigkeit |
| AU2001227020A1 (en) * | 2000-01-19 | 2001-07-31 | Given Imaging Ltd. | A system for detecting substances |
| WO2001069212A1 (en) * | 2000-03-14 | 2001-09-20 | Given Imaging Ltd. | Device and method for in vitro detection of blood |
| US20010036423A1 (en) * | 2000-03-22 | 2001-11-01 | Fuji Photo Film Co., Ltd. | Dry analytical element |
| US6989891B2 (en) * | 2001-11-08 | 2006-01-24 | Optiscan Biomedical Corporation | Device and method for in vitro determination of analyte concentrations within body fluids |
| JP3910102B2 (ja) * | 2002-04-25 | 2007-04-25 | 富士フイルム株式会社 | 乾式分析要素及び分析キット |
| EP1717582B1 (en) * | 2004-02-20 | 2011-06-15 | FUJIFILM Corporation | Multilayer analysis element |
| US7986337B2 (en) * | 2004-09-27 | 2011-07-26 | Given Imaging Ltd. | System and method for editing an image stream captured in vivo |
| US7842086B2 (en) * | 2005-01-07 | 2010-11-30 | Visioncare Ophthalmic Technologies, Inc. | Mirror implant |
| US8738106B2 (en) | 2005-01-31 | 2014-05-27 | Given Imaging, Ltd | Device, system and method for in vivo analysis |
| US8663093B2 (en) * | 2006-04-03 | 2014-03-04 | Given Imaging Ltd. | Device, system and method for in-vivo analysis |
| US7738094B2 (en) | 2007-01-26 | 2010-06-15 | Becton, Dickinson And Company | Method, system, and compositions for cell counting and analysis |
| US8515507B2 (en) * | 2008-06-16 | 2013-08-20 | Given Imaging Ltd. | Device and method for detecting in-vivo pathology |
| WO2011011462A1 (en) | 2009-07-20 | 2011-01-27 | Optiscan Biomedical Corporation | Adjustable connector and dead space reduction |
| US8682142B1 (en) | 2010-03-18 | 2014-03-25 | Given Imaging Ltd. | System and method for editing an image stream captured in-vivo |
| CN106923779A (zh) | 2010-04-28 | 2017-07-07 | 基文影像公司 | 用于显示体内图像部分的系统和方法 |
| US8873816B1 (en) | 2011-04-06 | 2014-10-28 | Given Imaging Ltd. | Method and system for identification of red colored pathologies in vivo |
| CN103917870B (zh) | 2011-11-16 | 2016-04-13 | 贝克顿·迪金森公司 | 用于检测样品中的分析物的方法和系统 |
| BR112015010695B1 (pt) | 2013-01-11 | 2023-03-07 | Becton, Dickinson And Company | Dispositivo microfluídico e método para realizar um ensaio de uma amostra líquida, método para formar um dispositivo microfluídico, sistema e kit |
| US9324145B1 (en) | 2013-08-08 | 2016-04-26 | Given Imaging Ltd. | System and method for detection of transitions in an image stream of the gastrointestinal tract |
| ES2856191T3 (es) | 2013-11-06 | 2021-09-27 | Becton Dickinson Co | Dispositivos microfluídicos y métodos de uso de los mismos |
| JP6518245B2 (ja) | 2013-11-13 | 2019-05-22 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | 光学撮像システム及びそれを用いた方法 |
| WO2016060793A1 (en) | 2014-10-14 | 2016-04-21 | Becton, Dickinson And Company | Blood sample management using open cell foam |
| US11298061B2 (en) | 2014-10-14 | 2022-04-12 | Becton, Dickinson And Company | Blood sample management using open cell foam |
| JP6426832B2 (ja) | 2015-03-10 | 2018-11-21 | ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ | 生物体液の極微標本管理装置 |
| EP3344390B1 (en) | 2015-09-01 | 2021-01-20 | Becton, Dickinson and Company | Depth filtration device for separating specimen phases |
| CN115920984B (zh) * | 2022-12-07 | 2024-05-07 | 南开大学 | 一种用于贫血标志物高灵敏检测的集成化纸基微流控芯片 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2332760A1 (de) * | 1972-06-30 | 1974-01-17 | Eastman Kodak Co | Mehrschichtiges analytisches element fuer die quantitative spektrophotometrische analyse |
| US4057394A (en) * | 1976-05-24 | 1977-11-08 | Miles Laboratories, Inc. | Test device and method for determining blood hemoglobin |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4250257A (en) * | 1978-08-24 | 1981-02-10 | Technicon Instruments Corporation | Whole blood analyses in porous media |
-
1980
- 1980-01-07 JP JP43580A patent/JPS5697872A/ja active Granted
-
1981
- 1981-01-07 GB GB8100383A patent/GB2069132B/en not_active Expired
- 1981-01-07 US US06/223,062 patent/US4337222A/en not_active Expired - Lifetime
- 1981-01-07 DE DE19813100156 patent/DE3100156A1/de active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2332760A1 (de) * | 1972-06-30 | 1974-01-17 | Eastman Kodak Co | Mehrschichtiges analytisches element fuer die quantitative spektrophotometrische analyse |
| US4057394A (en) * | 1976-05-24 | 1977-11-08 | Miles Laboratories, Inc. | Test device and method for determining blood hemoglobin |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0133782B2 (US06515009-20030204-C00004.png) | 1989-07-14 |
| JPS5697872A (en) | 1981-08-06 |
| US4337222A (en) | 1982-06-29 |
| GB2069132B (en) | 1984-05-23 |
| DE3100156C2 (US06515009-20030204-C00004.png) | 1988-11-10 |
| GB2069132A (en) | 1981-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3100156A1 (de) | Material zur bestimmung der haemoglobinkonzentration | |
| DE69702934T2 (de) | Trennung von Plasma oder Serum von Vollblut | |
| DE3021166C2 (US06515009-20030204-C00004.png) | ||
| DE3140239C2 (US06515009-20030204-C00004.png) | ||
| EP0154839B1 (de) | Testvorrichtung und Methode zum Nachweis einer Komponente einer flüssigen Probe | |
| DE68923996T2 (de) | Testvorrichtung mit bestimmtem Volumen. | |
| EP0045476B1 (de) | Verfahren zur Abtrennung von Plasma oder Serum aus Vollblut | |
| EP0175990B1 (de) | Membran für Reagenzträgerschichten, Verfahren zu deren Herstellung, sowie deren Verwendung in analytischen Mitteln und Analysenverfahren | |
| DE2723183C3 (de) | Prüfmittel zur Bestimmung von Hämoglobin in einer Blutprobe | |
| DE69735554T2 (de) | Hochgradig assymetrische, hydrophile mikrofiltrationsmembranen mit grossen porendurchmessern | |
| EP0064710B1 (de) | Mehrschichtiges Testmittel zum Nachweis einer Komponente einer flüssigen Probe | |
| DE2801476A1 (de) | Kolorimetrisches verfahren fuer die bestimmung von bilirubin | |
| DE2801477C2 (de) | Verfahren und analytisches Element für die Bestimmung von Bilirubin | |
| DE2922958A1 (de) | Mehrschichtiges integrales element zur chemischen analyse von blut | |
| DE3809523A1 (de) | Verfahren zur herstellung von poroesen membranen, die damit hergestellten membranen und deren verwendung als traegermatrices in teststreifen | |
| DE2332760A1 (de) | Mehrschichtiges analytisches element fuer die quantitative spektrophotometrische analyse | |
| DD142607A5 (de) | Verfahren und testvorrichtung zur bestimmung des vorhandenseins einer probenkomponente | |
| DE4015589A1 (de) | Vorrichtung und deren verwendung zur abtrennung von plasma aus vollblut | |
| DE2532918A1 (de) | Integrales analytisches element fuer die analyse von fluessigkeiten | |
| DE3049382A1 (de) | Material zur bestimmung des haematokritwertes | |
| DE3687959T2 (de) | Integrierendes mehrschichtiges analytisches element. | |
| EP0575364B1 (de) | Testträger zur bestimmung eines analyten aus vollblut | |
| EP0995992A2 (de) | Spreitschichten, Netzmittel zu ihrer Herstellung und deren Verwendung in Teststreifen | |
| EP0586789B1 (de) | Gleichmässig verteilte Anreicherung einer in Lösung vorliegenden Substanz auf der feinporigen Seite einer asymmetrisch porösen Membran | |
| DE3587159T2 (de) | Analytisches element zur analyse einer vollblutprobe. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8128 | New person/name/address of the agent |
Representative=s name: KOHLER, M., DIPL.-CHEM. DR.RER.NAT., 8000 MUENCHEN |
|
| 8128 | New person/name/address of the agent |
Representative=s name: SOLF, A., DR.-ING., 8000 MUENCHEN ZAPF, C., DIPL.- |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8363 | Opposition against the patent | ||
| 8331 | Complete revocation |